24 October 2026RSS feed
PR●Press Release IndiaTHE BUSINESS ANNOUNCEMENT WIRE
Business announcements.
Direct from the source.
NEWSROOM / INDIA

The latest on the wire

Browse announcements from the Press Release India archive.

UPDATED THROUGHOUT THE DAY
Business wire13076

Four Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, Presented at DDW 2023

Data presentations highlight Ferring's microbiome leadership and commitment to ongoing research Analyses review safety and efficacy data across various patient populations with co-morbidities and when treatment is administered by colonoscopy Additional analysi